PURPOSE: To determine the prevalence of hypertrophic cardiomyopathy in China. METHODS: This epidemiologic investigation was performed in 8080 adults from nine communities across nine provinces in China from October 2001 to February 2002, using a multistage, random sample design. Hypertrophic cardiomyopathy was defined as nondilated ventricular hypertrophy, documented by echocardiography, that was not caused by any known cardiac or systemic disease. RESULTS: Of the 4064 men and 4016 women who were screened, 13 (0.16%; 9 men and 4 women) had definite echocardiographic evidence for hypertrophic cardiomyopathy. The age- and sex-adjusted prevalence was about 80 per 100,000 adults. CONCLUSION: Hypertrophic cardiomyopathy is not rare in China. Based on the estimated prevalence, there are at least 1 million cases in China.
PURPOSE: To determine the prevalence of hypertrophic cardiomyopathy in China. METHODS: This epidemiologic investigation was performed in 8080 adults from nine communities across nine provinces in China from October 2001 to February 2002, using a multistage, random sample design. Hypertrophic cardiomyopathy was defined as nondilated ventricular hypertrophy, documented by echocardiography, that was not caused by any known cardiac or systemic disease. RESULTS: Of the 4064 men and 4016 women who were screened, 13 (0.16%; 9 men and 4 women) had definite echocardiographic evidence for hypertrophic cardiomyopathy. The age- and sex-adjusted prevalence was about 80 per 100,000 adults. CONCLUSION:Hypertrophic cardiomyopathy is not rare in China. Based on the estimated prevalence, there are at least 1 million cases in China.
Authors: Yigal M Pinto; Arthur Aam Wilde; Ingrid Aw van Rijsingen; Imke Christiaans; Ronald H Lekanne Deprez; Perry M Elliott Journal: Eur J Hum Genet Date: 2011-01-26 Impact factor: 4.246
Authors: Stephen Pan; Colleen A Caleshu; Kyla E Dunn; Marcia J Foti; Maura K Moran; Oretunlewa Soyinka; Euan A Ashley Journal: Circ Cardiovasc Genet Date: 2012-10-16